Ozempic maker sues US rival over ad campaign

Summary

Novo Nordisk has claimed that Eli Lilly is using bad data to compare the companies' weight-loss and diabetes products in its ads.

News Radar provides aggregated summaries. Full content and copyright remain with the original publisher.